Sodium in PDB 8qng: Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1)

The structure of Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1), PDB code: 8qng was solved by M.Schimpl, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	47.94 / 2.20
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	55.578, 72.045, 94.786, 90, 90, 90
R / Rfree (%)	21.9 / 29.5

The structure of Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1) also contains other interesting chemical elements:

Zinc

(Zn)

2 atoms

The binding sites of Sodium atom in the Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1) (pdb code 8qng). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1), PDB code: 8qng:

Sodium binding site 1 out of 1 in the Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1)


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Crystal Structure of the E3 Ubiquitin Ligase Cbl-B with An Allosteric Inhibitor (Benzodiazepine Hts Hit Compound 1) within 5.0Å range: probe atom residue distance (Å) B Occ A:Na504 b:41.6 occ:1.00 OE2 A:GLU232 2.2 52.3 1.0 OD1 A:ASN225 2.3 43.5 1.0 OD1 A:ASP221 2.4 36.4 1.0 O A:TYR227 2.4 39.3 1.0 OE1 A:GLU232 2.5 51.7 1.0 OG1 A:THR223 2.5 34.8 1.0 CD A:GLU232 2.7 50.0 1.0 O A:HOH605 2.7 21.6 1.0 CG A:ASN225 3.4 42.0 1.0 CG A:ASP221 3.4 37.1 1.0 C A:TYR227 3.5 38.8 1.0 CB A:THR223 3.9 33.6 1.0 ND2 A:ASN225 3.9 42.3 1.0 N A:THR223 4.0 32.9 1.0 CA A:ASP221 4.1 35.4 1.0 CG A:GLU232 4.2 43.3 1.0 OD2 A:ASP221 4.2 38.1 1.0 CB A:ASP221 4.2 35.8 1.0 CA A:ILE228 4.3 38.1 1.0 N A:ILE228 4.3 38.2 1.0 N A:ASN225 4.3 35.6 1.0 CA A:THR223 4.3 33.0 1.0 N A:TYR227 4.3 39.0 1.0 CA A:TYR227 4.4 39.0 1.0 C A:ASP221 4.4 34.8 1.0 CG2 A:THR223 4.4 33.0 1.0 N A:LEU222 4.4 33.3 1.0 N A:CYS224 4.5 31.4 1.0 C A:THR223 4.5 32.4 1.0 CB A:TYR227 4.6 39.3 1.0 N A:SER229 4.6 37.7 1.0 CB A:ASN225 4.7 38.4 1.0 CD1 A:ILE228 4.7 40.4 1.0 CA A:ASN225 4.9 37.2 1.0 C A:ILE228 4.9 37.9 1.0 CB A:GLU232 4.9 40.4 1.0

M.Schimpl, M.Schimpl. N/A N/A.